{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:21:56Z","timestamp":1785795716278,"version":"3.56.0"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,18]]},"DOI":"10.7759\/cureus.26961","type":"journal-article","created":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T10:21:22Z","timestamp":1658139682000},"source":"Crossref","is-referenced-by-count":1,"title":["A Rare Case of Severe Manifestation of COVID-19 Infection Presenting as Immune-Related Thrombotic Thrombocytopenic Purpura With Multiorgan Involvement Treated With Plasmapheresis, Steroids, Rituximab, and Caplacizumab"],"prefix":"10.7759","author":[{"given":"Saikiran","family":"Mandyam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed S","family":"Fatmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Banzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paramjit","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamini","family":"Katamreddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devam","family":"Parghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Awais","family":"Farooq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamza","family":"Liaqat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnamohan","family":"Basarakodu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Diagnosis of immune TTP. (2022). Accessed. June 12, 2022: https:\/\/www.uptodate.com\/contents\/diagnosis-of-immune-ttp?search=undefined&amp;source=search_result&amp;selectedTitle=1~150&amp;u...."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-11-4490","article-title":"ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases","volume":"106","author":"Rieger M","year":"2005","unstructured":"Rieger M, Mannucci PM, Kremer Hovinga JA, et al.. ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases. Blood. 2005, 106:1262-7. 10.1182\/blood-2004-11-4490","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199108083250604","article-title":"Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura","volume":"325","author":"Rock GA","year":"1991","unstructured":"Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, Spasoff RA. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med. 1991, 325:393-7. 10.1056\/NEJM199108083250604","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2017009308","article-title":"Cyclosporine or steroids as an adjunct to plasma exchange in the treatment of immune-mediated thrombotic thrombocytopenic purpura","volume":"1","author":"Cataland SR","year":"2017","unstructured":"Cataland SR, Kourlas PJ, Yang S, et al.. Cyclosporine or steroids as an adjunct to plasma exchange in the treatment of immune-mediated thrombotic thrombocytopenic purpura. Blood Adv. 2017, 1:2075-82. 10.1182\/bloodadvances.2017009308","journal-title":"Blood Adv"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-009-0877-5","article-title":"High versus standard dose methylprednisolone in the acute phase of idiopathic thrombotic thrombocytopenic purpura: a randomized study","volume":"89","author":"Balduini CL","year":"2010","unstructured":"Balduini CL, Gugliotta L, Luppi M, et al.. High versus standard dose methylprednisolone in the acute phase of idiopathic thrombotic thrombocytopenic purpura: a randomized study. Ann Hematol. 2010, 89:591-6. 10.1007\/s00277-009-0877-5","journal-title":"Ann Hematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1505533","article-title":"Caplacizumab for acquired thrombotic thrombocytopenic purpura","volume":"374","author":"Peyvandi F","year":"2016","unstructured":"Peyvandi F, Scully M, Kremer Hovinga JA, et al.. Caplacizumab for acquired thrombotic thrombocytopenic purpura. N Engl J Med. 2016, 374:511-22. 10.1056\/NEJMoa1505533","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1806311","article-title":"Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura","volume":"380","author":"Scully M","year":"2019","unstructured":"Scully M, Cataland SR, Peyvandi F, et al.. Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura. N Engl J Med. 2019, 380:335-46. 10.1056\/NEJMoa1806311","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(17)30026-1","article-title":"Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study","volume":"4","author":"Bendapudi PK","year":"2017","unstructured":"Bendapudi PK, Hurwitz S, Fry A, et al.. Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study. Lancet Haematol. 2017, 4:e157-4. 10.1016\/S2352-3026(17)30026-1","journal-title":"Lancet Haematol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13571","article-title":"Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies","volume":"15","author":"Scully M","year":"2017","unstructured":"Scully M, Cataland S, Coppo P, et al.. Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies. J Thromb Haemost. 2017, 15:312-22. 10.1111\/jth.13571","journal-title":"J Thromb Haemost"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/102039-a-rare-case-of-severe-manifestation-of-covid-19-infection-presenting-as-immune-related-thrombotic-thrombocytopenic-purpura-with-multiorgan-involvement-treated-with-plasmapheresis-steroids-rituximab-and-caplacizumab","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:45:05Z","timestamp":1707507905000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/102039-a-rare-case-of-severe-manifestation-of-covid-19-infection-presenting-as-immune-related-thrombotic-thrombocytopenic-purpura-with-multiorgan-involvement-treated-with-plasmapheresis-steroids-rituximab-and-caplacizumab"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,18]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.26961","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,18]]}}}